K D Wenstrom1, G L Johanning, K E Johnston, M DuBard. 1. Center for Research in Women's Health, Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, 35249-7333, USA.
Abstract
OBJECTIVE: The aim of this study was determine whether the cytosine-to-thymine mutation at base 677 of the gene for methylenetetrahydrofolate reductase (C677T MTHFR ), which has been associated with neural tube defects, is also associated with congenital cardiac malformations. STUDY DESIGN: Amniotic fluid homocysteine levels were measured and the presence or absence of the C677T MTHFR mutation in amniocytes was determined in stored amniotic fluid obtained from 26 pregnancies complicated by isolated (presumed multifactorial) fetal cardiac defects and from 116 normal pregnancies. RESULTS: The pregnancies affected by fetal cardiac defects had higher amniotic fluid homocysteine levels (1.7 +/- 1.7 vs 1.0 +/- 0.7 micromol/L; P =.07) and included more samples with homocysteine levels >90th percentile (27% vs 9%; P =.02) and more cases with the C677T MTHFR mutation (35% vs 13%; P =.01). Fifty percent of cases had either a high homocysteine level or the C677T MTHFR mutation (50% vs 20%; P =.003) and 12% had both (12% vs 0%; P =.0006). CONCLUSION: Fifty percent of these isolated congenital cardiac defects were associated with either the C677T MTHFR mutation or elevated amniotic fluid homocysteine levels, or both. This finding adds to what is already known about the multiple and complex biochemical and developmental functions of the homocysteine pathway.
OBJECTIVE: The aim of this study was determine whether the cytosine-to-thymine mutation at base 677 of the gene for methylenetetrahydrofolate reductase (C677TMTHFR ), which has been associated with neural tube defects, is also associated with congenital cardiac malformations. STUDY DESIGN:Amniotic fluid homocysteine levels were measured and the presence or absence of the C677TMTHFR mutation in amniocytes was determined in stored amniotic fluid obtained from 26 pregnancies complicated by isolated (presumed multifactorial) fetal cardiac defects and from 116 normal pregnancies. RESULTS: The pregnancies affected by fetal cardiac defects had higher amniotic fluid homocysteine levels (1.7 +/- 1.7 vs 1.0 +/- 0.7 micromol/L; P =.07) and included more samples with homocysteine levels >90th percentile (27% vs 9%; P =.02) and more cases with the C677TMTHFR mutation (35% vs 13%; P =.01). Fifty percent of cases had either a high homocysteine level or the C677TMTHFR mutation (50% vs 20%; P =.003) and 12% had both (12% vs 0%; P =.0006). CONCLUSION: Fifty percent of these isolated congenital cardiac defects were associated with either the C677TMTHFR mutation or elevated amniotic fluid homocysteine levels, or both. This finding adds to what is already known about the multiple and complex biochemical and developmental functions of the homocysteine pathway.
Authors: Kerina J Denny; Christina F Kelly; Vinod Kumar; Katey L Witham; Robert M Cabrera; Richard H Finnell; Stephen M Taylor; Angela Jeanes; Trent M Woodruff Journal: Birth Defects Res A Clin Mol Teratol Date: 2016-02-22
Authors: Xinyu Tang; Mario A Cleves; Todd G Nick; Ming Li; Stewart L MacLeod; Stephen W Erickson; Jingyun Li; Gary M Shaw; Bridget S Mosley; Charlotte A Hobbs Journal: Am J Med Genet A Date: 2015-04-02 Impact factor: 2.802
Authors: Wendy N Nembhard; Xinyu Tang; Jingyun Li; Stewart L MacLeod; Joseph Levy; Gerald B Schaefer; Charlotte A Hobbs Journal: Am J Med Genet A Date: 2018-02-05 Impact factor: 2.802
Authors: Lei Chen; Erin M Bell; Marilyn L Browne; Charlotte M Druschel; Paul A Romitti; Rebecca J Schmidt; Trudy L Burns; Roxana Moslehi; Richard S Olney Journal: Birth Defects Res A Clin Mol Teratol Date: 2012-08-18
Authors: Gary M Shaw; Wei Lu; Huiping Zhu; Wei Yang; Farren B S Briggs; Suzan L Carmichael; Lisa F Barcellos; Edward J Lammer; Richard H Finnell Journal: BMC Med Genet Date: 2009-06-03 Impact factor: 2.103